SBSylvian Bauer

Sylvian Bauer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sylvian Bauer has a total of 77 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Virus-against-virus dominant-negative interference strategy targeting a viral CC chemokine prevents cytomegalovirus-related neurodevelopmental pathogenesis

    by Sylvian Bauer, Sarah Tarhini, Emmanuelle Buhler, Saswati Saha, Thomas Stamminger, Daniel N. Streblow, Nail Burnashev, Hervé Luche, Pierre Szepetowski

    Background: Congenital cytomegalovirus (CMV) infections are one leading cause of human neurodevelopmental disorders. Increasing evidence for the pathogenic involvement of brain immune alterations was obtained in the recent years. Host and virus-encoded chemokines might play important roles in CMV-related neuropathogenesis by regulating leukocyte trafficking and microglia recruitment in the CMV-infected brains, and by interfering with key neurodevelopmental steps. In a rat model of CMV infection of the fetal brain in utero that leads to detrimental neurologic and other severe phenotypes postnatally, we reported on the early alteration of microglia and on the infiltration of the infected brains by lymphoid and myeloid cells. Particularly, expression of the r129 gene encoding the viral chemokine RCK3 was detected as early as 24h post-infection; together with the previously reported chemotaxis properties exerted by RCK3 on lymphocytes and on macrophages in vitro , this suggested that RCK3 might be involved in the brain immune cell alterations seen in the CMV-infected developing brains, and in the related neuropathogenesis. Methods: Infection of the rat fetal brain was done by intracerebroventricular injections in utero of either rat CMV encoding wild-type (wt) RCK3 (RCMV-wt), or a mutant CMV counterpart encoding RCK3 with a deletion in its chemokine domain (RCMV-r129ΔNT). As RCMV-r129ΔNT had shown dominant-negative effects on the chemotaxis properties of RCK3 in vitro , simultaneous and successive co-infection rescue assays were also performed. The detrimental postnatal phenotypes in vivo and the epileptiform activity ex vivo usually detected after infection of the rat developing brain with RCMV-wt were monitored in the RCMV-r129ΔNT condition and in co-infection assays. Results: In sharp contrast with RCMV-wt whose infection of the fetal brain led to decreased postnatal survival, impaired sensorimotor development, hindlimb hyperextension and epileptic seizures in neonatal pups, RCMV-r129ΔNT infection was not associated with any severe postnatal phenotype in vivo . Consistently, the epileptiform activity recorded in most neocortical slices from RCMV-wt-infected pups was not detected in any slice from RCMV-r129ΔNT-infected pups. Simultaneous co-infection assays led to dramatic prevention against the postnatal phenotypes in vivo and the altered network activity ex vivo , revealing a dose-dependent rescuing effect exerted by RCMV-r129ΔNT on RCMV-wt. Importantly, successful rescue was also obtained when the mutant RCMV-r129ΔNT was inoculated in the fetal brains either before or after infection with RCMV-wt. Significance: Our data demonstrate the crucial neuropathogenic role of RCK3 CMV chemokine in vivo . The dramatic success and apparent safety of the dominant-negative RCK3 rescue assays in vivo provide a proof-of-principle for the beneficial use of a virus-against-virus approach against CMV-related pathogenesis.

  • Open Access

    Cytomegalovirus infection of the fetal brain: intake of aspirin during pregnancy blunts neurodevelopmental pathogenesis in the offspring

    by Sarah Tarhini, Carla Crespo-Quiles, Emmanuelle Buhler, Louison Pineau, Emilie Pallesi-Pocachard, Solène Villain, Saswati Saha, Lucas Silvagnoli, Thomas Stamminger, Hervé Luche, et al.

    Congenital cytomegalovirus (CMV) infections represent one leading cause of human neurodevelopmental disorders. Despite their high prevalence and severity, no satisfactory therapy is available and pathophysiology remains elusive. The pathogenic involvement of immune processes occurring in infected developing brains has been increasingly documented. Here, we have used our previously validated rat model of CMV infection of the fetal brain in utero to test whether the maternal administration of four different drugs with immunomodulatory properties would have an impact on the detrimental postnatal outcome of CMV infection. CMV infection of the rat fetal brain was done intracerebroventricularly. Each of the drugs, including acetylsalicylic acid (aspirin, ASA), a classical inhibitor of cyclooxygenases Cox-1 and Cox-2, the two key rate-limiting enzymes of the arachidonic acid-to-prostaglandins (PG) synthesis pathway, was administered to pregnant dams until delivery. ASA was selected for subsequent analyses based on the improvement in postnatal survival. A combination of qRT-PCR, mass spectrometry-based targeted lipidomics, immunohistochemistry experiments, monitoring of neurologic phenotypes and electrophysiological recordings was used to assess the impact of ASA in CMV-infected samples and pups. The postnatal consequences of CMV infection were also analyzed in rats knocked-out (KO) for Cox-1. Increased PGE2 levels and increased proportions of Cox-1+ and Cox-2+ microglia were detected in CMV-infected developing brains. Maternal intake of ASA led to decreased proportion of Cox-1+ fetal, but not neonatal, microglia, while leaving the proportions of Cox-2+ microglia unchanged. Maternal intake of ASA also improved the key postnatal in vivo phenotypes caused by CMV infection and dramatically prevented against the spontaneous epileptiform activity recorded in neocortical slices from CMV-infected pups. In contrast with maternal intake of ASA, Cox-1 KO pups displayed no improvement in the in vivo phenotypes after CMV infection. However, as with ASA administration, the spontaneous epileptiform activity was dramatically inhibited in neocortical slices from CMV-infected, Cox-1 KO pups. Overall, our data indicate that, in the context of CMV infection of the fetal brain, maternal intake of ASA during pregnancy improved CMV-related neurodevelopmental alterations in the offspring, likely via both Cox-1 dependent and Cox-1 independent mechanisms, and provide proof-of-principle for the use of ASA against the detrimental outcomes of congenital CMV infections.


  • Open Access

    Cytomegalovirus Infection of the Rat Developing Brain In Utero Prominently Targets Immune Cells and Promotes Early Microglial Activation

    by Robin Cloarec, Sylvian Bauer, Hervé Luche, Emmanuelle Buhler, Emilie Pallesi-Pocachard, Manal Salmi, Sandra Courtens, Annick Massacrier, Natacha Teissier, Françoise Watrin, et al.

    Congenital cytomegalovirus infections are a leading cause of neurodevelopmental disorders in human and represent a major health care and socio-economical burden. In contrast with this medical importance, the pathophysiological events remain poorly known. Murine models of brain cytomegalovirus infection, mostly neonatal, have brought recent insights into the possible pathogenesis, with convergent evidence for the alteration and possible involvement of brain immune cells. In order to confirm and expand those findings, particularly concerning the early developmental stages following infection of the fetal brain, we have created a model of in utero cytomegalovirus infection in the developing rat brain. Rat cytomegalovirus was injected intraventricularly at embryonic day 15 (E15) and the brains analyzed at various stages until the first postnatal day, using a combination of gene expression analysis, immunohistochemistry and multicolor flow cytometry experiments. Rat cytomegalovirus infection was increasingly seen in various brain areas including the choroid plexi and the ventricular and subventricular areas and was prominently detected in CD45low/int, CD11b+ microglial cells, in CD45high, CD11b+ cells of the myeloid lineage including macrophages, and in CD45+, CD11b– lymphocytes and non-B non-T cells. In parallel, rat cytomegalovirus infection of the developing rat brain rapidly triggered a cascade of pathophysiological events comprising: chemokines upregulation, including CCL2-4, 7 and 12; infiltration by peripheral cells including B-cells and monocytes at E17 and P1, and T-cells at P1; and microglia activation at E17 and P1. In line with previous findings in neonatal murine models and in human specimen, our study further suggests that neuroimmune alterations might play critical roles in the early stages following cytomegalovirus infection of the brain in utero. Further studies are now needed to determine which role, whether favorable or detrimental, those putative double-edge swords events actually play.


  • An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism

    by Hamid Meziane, Fabienne Schaller, Sylvian Bauer, Claude Villard, Valery Matarazzo, Fabrice Riet, Gilles Guillon, Daniel Lafitte, Michel G. Desarmenien, Maithé Tauber, et al.


  • Open Access

    Cerebral Cell Renewal in Adult Mice Controls the Onset of Obesity

    by Alexandra Gouazé, Xavier Brenachot, Caroline Rigault, Alice Krezymon, Camille Rauch, Emmanuelle Nédélec, Aleth Lemoine, Jean Gascuel, Sylvian Bauer, Luc Pénicaud, et al.

    The hypothalamus plays a crucial role in the control of the energy balance and also retains neurogenic potential into adulthood. Recent studies have reported the severe alteration of the cell turn-over in the hypothalamus of obese animals and it has been proposed that a neurogenic deficiency in the hypothalamus could be involved in the development of obesity. To explore this possibility, we examined hypothalamic cell renewal during the homeostatic response to dietary fat in mice, i.e., at the onset of diet-induced obesity. We found that switching to high-fat diet (HFD) accelerated cell renewal in the hypothalamus through a local, rapid and transient increase in cell proliferation, peaking three days after introducing the HFD. Blocking HFD-induced cell proliferation by central delivery of an antimitotic drug prevented the food intake normalization observed after HFD introduction and accelerated the onset of obesity. This result showed that HFD-induced dividing brain cells supported an adaptive anorectic function. In addition, we found that the percentage of newly generated neurons adopting a POMC-phenotype in the arcuate nucleus was increased by HFD. This observation suggested that the maturation of neurons in feeding circuits was nutritionally regulated to adjust future energy intake. Taken together, these results showed that adult cerebral cell renewal was remarkably responsive to nutritional conditions. This constituted a physiological trait required to prevent severe weight gain under HFD. Hence this report highlighted the amazing plasticity of feeding circuits and brought new insights into our understanding of the nutritional regulation of the energy balance.


  • Open Access

    Inactivation ofSocs3in the Hypothalamus Enhances the Hindbrain Response to Endogenous Satiety Signals via Oxytocin Signaling

    by Valéry Matarazzo, Fabienne Schaller, Emmanuelle Nédélec, Alexandre Benani, Luc Pénicaud, Françoise Muscatelli, Emmanuel Moyse, Sylvian Bauer

    Leptin is an adipocyte-derived hormone that controls energy balance by acting primarily in the CNS, but its action is lost in common forms of obesity due to central leptin resistance. One potential mechanism for such leptin resistance is an increased hypothalamic expression of Suppressor of cytokine signaling 3 (Socs3), a feedback inhibitor of the Jak-Stat pathway that prevents Stat3 activation. Ample studies have confirmed the important role of Socs3 in leptin resistance and obesity. However, the degree to which Socs3 participates in the regulation of energy homeostasis in nonobese conditions remains largely undetermined. In this study, using adult mice maintained under standard diet, we demonstrate thatSocs3deficiency in the mediobasal hypothalamus (MBH) reduces food intake, protects against body weight gain, and limits adiposity, suggesting that Socs3 is necessary for normal body weight maintenance. Mechanistically, MBH Socs3-deficient mice display increased hindbrain sensitivity to endogenous, meal-related satiety signals, mediated by oxytocin signaling. Thus, oxytocin signaling likely mediates the effect of hypothalamic leptin on satiety circuits of the caudal brainstem. This provides an anatomical substrate for the effect of leptin on meal size, and more generally, a mechanism for how the brain controls short-term food intake as a function of the energetic stores available in the organism to maintain energy homeostasis. Any dysfunction in this pathway could potentially lead to overeating and obesity.


  • Open Access

    Alteration of Forebrain Neurogenesis after Cervical Spinal Cord Injury in the Adult Rat

    by Marie-Solenne Felix, Natalia Popa, Mehdi Djelloul, José Boucraut, Patrick Gauthier, Sylvian Bauer, Valery A. Matarazzo

    Spinal cord injury (SCI) triggers a complex cellular response at the injury site, leading to the formation of a dense scar tissue. Despite this local tissue remodeling, the consequences of SCI at the cellular level in distant rostral sites (i.e., brain), remain unknown. In this study, we asked whether cervical SCI could alter cell dynamics in neurogenic areas of the adult rat forebrain. To this aim, we quantified BrdU incorporation and determined the phenotypes of newly generated cells (neurons, astrocytes, or microglia) during the subchronic and chronic phases of injury. We find that subchronic SCI leads to a reduction of BrdU incorporation and neurogenesis in the olfactory bulb and in the hippocampal dentate gyrus. By contrast, subchronic SCI triggers an increased BrdU incorporation in the dorsal vagal complex of the hindbrain, where most of the newly generated cells are identified as microglia. In chronic condition 90 days after SCI, BrdU incorporation returns to control levels in all regions examined, except in the hippocampus, where SCI produces a long-term reduction of neurogenesis, indicating that this structure is particularly sensitive to SCI. Finally, we observe that SCI triggers an acute inflammatory response in all brain regions examined, as well as a hippocampal-specific decline in BDNF levels. This study provides the first demonstration that forebrain neurogenesis is vulnerable to a distal SCI.


  • Cytokine Control of Adult Neural Stem Cells

    by Sylvian Bauer

    The neuropoietic cytokine family includes interleukin‐6 (IL‐6), leukemia inhibitory factor (LIF), and ciliary neurotrophic factor (CNTF), among others. These cytokines have been shown to alter neural stem cell (NSC) self‐renewal and progenitor cell division and differentiation, which could be mediated by the Janus kinase‐signal transducer and activator of transcription (JAK/STAT) pathway. Using neurospheres from the adult mouse subventricular zone (SVZ), we found that acute or chronic exposure to LIF or CNTF differentially affects sphere development and sphere growth. Both cytokines also favor the amplification of NSCs. Contrasting results were obtained with IL‐6 or leptin, although both cytokines also activate the JAK/STAT pathway. Stimulating NSC self‐renewal in vivo could be of therapeutic interest for treating neurodegeneration. When applied to the adult mouse brain, chronic LIF stimulates NSC self‐renewal but prevents the emergence of more differentiated progeny. On the other hand, acute LIF treatment stimulates SVZ regeneration, most likely through an increase in NSCs. These results reveal that cytokine effects could vary as a function of exposure duration and suggest that, in the search for strategies to promote brain repair, in vivo acute LIF treatment could promote cell replacement.


  • The neuropoietic cytokine family in development, plasticity, disease and injury

    by Sylvian Bauer, Bradley J. Kerr, Paul H. Patterson

    Neuropoietic cytokines have a crucial role in nervous system development. Leukaemia inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF) have historically been associated with the development of astrocytes from neural stem and progenitor cells. With the discovery that some astrocytes are neurogenic, the potential of these cytokines to promote the development of astrocytes versus neural stem cells is being re-investigated. Cardiotrophin 1, but not LIF or CNTF, is involved in the temporal switch from neurogenesis to gliogenesis during nervous system development. Exogenous LIF stimulates mouse embryonic stem cell self-renewal in vitro, and adult neural stem cell self-renewal in vivo in the uninjured brain. Because endogenous LIF is transiently induced after many types of injury to the nervous system, LIF might be involved in progenitor cell recruitment after brain injury and could be used to promote brain repair. Neuropoietic cytokines are crucial in the response to injury. In certain settings they can act as trophic factors promoting survival and regeneration of injured axons. However, they are also intimately linked with inflammatory responses and reactive gliosis after injury, which can have negative consequences for neuronal survival and axon regeneration. While these cytokines might prove to be effective therapeutic tools to promote neuronal and oligodendrocyte survival in CNS diseases such as amyotrophic lateral sclerosis and multiple sclerosis, their ability to stimulate inflammatory and glial responses must be carefully monitored in order to limit unwanted side effects. IL-6 is implicated in long-term potentiation. These effects could occur through direct effects of interleukin-6 (IL-6) on neuronal excitability and through the regulation of Ca2+ influx. A role for IL-6 in learning and memory is supported by cognitive tests. In animal models, LIF modulates the hypothalamic–pituitary–adrenal axis response to stress, and both LIF and IL-6 induce depression-like behaviours. In humans, IL-6 could have a role in symptoms of fatigue, asthenia and anorexia in major depression and bipolar disorder. LIF, CNTF and IL-6 are involved in feeding behaviour and control of body weight. There are also indications that members of this cytokine family can regulate sleep, motor activity patterns, aggression and social interaction.